Assessment of the impact of COVID-19 experienced at different stages of gestation on perinatal outcomes and structural changes in the placenta

Abstract

BACKGROUND: At the beginning of the pandemic COVID-19, the attention of obstetricians and gynecologists was focused on studying the impact of SARS-CoV-2 on obstetric and perinatal outcomes. Currently, the dynamics of mutations in genes encoding SARS-CoV-2 proteins determines the emergence of a large number of new strains of the virus that are highly virulent. Given this fact, the problem of assessing the impact of COVID-19 on pregnancy outcomes also remains relevant.

AIM: The aim of this study was to assess the impact of the novel coronavirus infection (COVID-19) transmitted at different stages of gestation on perinatal outcomes and structural changes in the placenta.

MATERIALS AND METHODS: In 2022–2023, a prospective analysis of 113 cases of childbirth in women who had the novel coronavirus infection during pregnancy was carried out in obstetric institutions in Novosibirsk. The total sample of subjects was divided into three study groups using cluster analysis. Group 1 included 25 women who had SARS-CoV-2 at a gestation period of up to 16 weeks; Group 2 consisted of 61 patients who underwent COVID-19 at gestation period of 17 to 34 weeks; and Group 3 comprised 27 pregnant women in whom COVID-19 was detected after 34 weeks of pregnancy. The control group included 65 pregnant women who had a negative smear test result for SARS-CoV-2. Pathological examination of the placenta included macro- and microscopic studies. Statistical processing of the results was carried out using the IBM SPSS Statistics Version 25.0 program.

RESULTS: The most common fetal distress was observed in patients of Groups 1 and 2 (p = 0.002). We found an inverse correlation between the gestational age at which a woman suffered coronavirus infection and the volumetric density of capillaries and intervillous fibrinoid, as well as the percentage of formation of the syncytial-capillary membrane and villi with symplastic buds. On the contrary, a direct correlation between the gestational age and the volumetric density of connective tissue was found. Intervillusitis was more often observed in the placentas of women of Groups 1 and 2. Histitocytic infiltration was characteristic of the placentas of patients of Group 2.

CONCLUSIONS: The frequency of adverse perinatal outcomes and the intensity of structural changes in the placenta depend on the gestation period in which the patient suffered the novel coronavirus infection. The most significant structural changes in the placenta were detected in patients of Group 2.

Keywords

new coronavirus infection / COVID-19 / SARS-CoV-2 / pregnancy / perinatal outcomes / gestational age / structural changes in placenta

References

[1] Yakubina AA, Aksenov AN, Bocharova II, et al. A new coronavirus infection in pregnant women: risks for the mother and the newborn. Russian Bulletin of Obstetrician-Gynecologist. 2023;23(2):34–40. EDN: IULQPM doi: 10.17116/rosakush20232302134

[2] Якубина А.А., Аксенов А.Н., Бочарова И.И., и др. Новая коронавирусная инфекция у беременных: риски для матери и новорожденного // Российский вестник акушера-гинеколога. 2023. Т. 23, № 2. С. 34–40. EDN: IULQPM doi: 10.17116/rosakush20232302134

[3] Kazhigalikyzy R, Akhmetova ZhK, Donbaeva ZB, et al. Pregnancy and perinatal outcomes in women with coronavirus infection (COVID-19). Science of life and health. 2020;(4):94–100. (In Russ.) doi: 10.24411/1995-5871-2020-10129

[4] Кажигаликызы Р., Ахметова Ж.К., Донбаева З.Б., и др. Беременность и перинатальные исходы у женщин с коронавирусной инфекцией (COVID-19) // Наука о жизни и здоровье. 2020. № 4. С. 94–100. doi: 10.24411/1995-5871-2020-10129

[5] Meyra Potkonjak A, Gall V, Milosevic D, et al. Perinatal aspects of SARS-CoV-2 infection during pregnancy: a potential cause for concern. Acta Clin Croat. 2022;61(4):681–691. doi: 10.20471/acc.2022.61.04.15

[6] Meyra Potkonjak A., Gall V., Milosevic D., et al. Perinatal aspects of SARS-CoV-2 infection during pregnancy: a potential cause for concern // Acta Clin Croat. 2022. Vol. 61, N. 4. P. 681–691. doi: 10.20471/acc.2022.61.04.15

[7] Babic I, Alsomali F, Aljuhani S, et al. COVID-19 Pandemic and its impact on perinatal outcomes between symptomatic and asymptomatic women. Obstet Gynecol Int. 2022;2022. doi: 10.1155/2022/1756266

[8] Babic I., Alsomali F., Aljuhani S., et al. COVID-19 Pandemic and its impact on perinatal outcomes between symptomatic and asymptomatic women // Obstet Gynecol Int. 2022. Vol. 2022. doi: 10.1155/2022/1756266

[9] Voropaeva EE, Khaidukova YuV, Kazachkova EA, et al. Perinatal outcomes and morphological examination of placentas in pregnant women with critical lung lesions in new COVID-19 coronavirus infection. Ural Medical Journal. 2023;22(2):109–121. EDN: CXRCMN doi: 10.52420/2071-5943-2023-22-2-109-121

[10] Воропаева Е.Е., Хайдукова Ю.В., Казачкова Э.А., и др. Перинатальные исходы и результаты морфологического исследования плацент у беременных с критическим поражением легких при новой коронавирусной инфекции COVID-19 // Уральский медицинский журнал. 2023. Т. 22, № 2. С. 109–121. EDN: CXRCMN doi: 10.52420/2071-5943-2023-22-2-109-121

[11] Giordano G, Petrolini C, Corradini E, et al. COVID-19 in pregnancy: placental pathological patterns and effect on perinatal outcome in five cases. Diagn Pathol. 2021;16(1):88. doi: 10.1186/s13000-021-01148-6

[12] Giordano G., Petrolini C., Corradini E., et al. COVID-19 in pregnancy: placental pathological patterns and effect on perinatal outcome in five cases // Diagn Pathol. 2021. Vol. 16, N. 1. P. 88. doi: 10.1186/s13000-021-01148-6

[13] Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020;369. doi: 10.1136/bmj.m2107

[14] Knight M., Bunch K., Vousden N., et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study // BMJ. 2020. Vol. 369. doi: 10.1136/bmj.m2107

[15] Wong YP, Tan GC, Omar SZ, et al. SARS-CoV-2 infection in pregnancy: placental histomorphological patterns, disease severity and perinatal outcomes. Int J Environ Res Public Health. 2022;19(15). doi: 10.3390/ijerph19159517

[16] Wong Y.P., Tan G.C., Omar S.Z., et al. SARS-CoV-2 infection in pregnancy: placental histomorphological patterns, disease severity and perinatal outcomes // Int J Environ Res Public Health. 2022. Vol. 19, N. 15. doi: 10.3390/ijerph19159517

[17] Sharps MC, Hayes DJL, Lee S, et al. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection. Placenta. 2020;101:13–29. doi: 10.1016/j.placenta.2020.08.018

[18] Sharps M.C., Hayes D.J.L., Lee S., et al. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection // Placenta. 2020. Vol. 101. P. 13–29. doi: 10.1016/j.placenta.2020.08.018

[19] Frank G, Koval’skiy GB, Zayrat’yants OV, et al. Rules for conducting pathological studies of the placenta. Class XV and XVI ICD-10. Clinical recommendations of the Russian Society of Pathologists. Moscow; 2017. Available from: https://www.old.patolog.ru/2017/placenta_study.pdf. (In Russ.)

[20] Франк Г.А., Ковальский Г.Б., Зайратьянц О.В., и др. Правила проведения патологоанатомических исследований плаценты. Класс XV и XVI МКБ-10. Клинические рекомендации Российского общества патологоанатомов. Москва, 2017. Режим доступа: https://www.old.patolog.ru/2017/placenta_study.pdf. Дата обращения: 12.12.2023.

[21] Volkova OV, Eletskiy YuK. Fundamentals of histology with histological techniques. Moscow: Meditsina;1982. (In Russ.)

[22] Волкова О.В., Елецкий Ю.К. Основы гистологии с гистологической техникой. Москва: Медицина, 1982.

[23] Buchwalow IB, Bocker W, editors. Immunohistochemistry: basics and methods. Berlin: Springer; 2010. doi: 10.1007/978-3-642-04609-4

[24] Buchwalow I.B., Bocker W., editors. Immunohistochemistry: basics and methods. Berlin: Springer, 2010. doi: 10.1007/978-3-642-04609-4

[25] Dabbs DG. Diagnostic Immunohistochemistry: theranostic and genomic applications. 5th ed. Philadelphia, PA: Elsevier/Saunders; 2019.

[26] Dabbs D.G. Diagnostic immunohistochemistry: theranostic and genomic applications. 5th ed. Philadelphia: Elsevier/Saunders, 2019.

[27] Avtandilov GG. Medical morphometry: manual. Moscow: Meditsina; 1990. (In Russ.)

[28] Автандилов Г.Г. Медицинская морфометрия: руководство. Москва: Медицина, 1990.

[29] International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. J Pharmacol Pharmacother. 2010;1(1):42–58.

[30] International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication // J Pharmacol Pharmacother. 2010. Vol. 1, N. 1. P. 42–58.

[31] Lang TA, Altman DG. Statistical analyses and methods in the published literature: the SAMPL guidelines. Medical Writing. 2016;25(3):31–36. doi: 10.18243/eon/2016.9.7.4

[32] Lang T.A., Altman D.G. Statistical analyses and methods in the published literature: the SAMPL guidelines // Medical Writing. 2016. Vol. 25, N. 3. P. 31–36. doi: 10.18243/eon/2016.9.7.4

[33] Kolesnikova YeP, Kuzenkova LM, Savostyanov KV, et al. Clinical cases of leukoencephalopathy with predominant lesion of the brain stem, spinal cord and high blood lactate in the mr spectroscopy (mitochondrial aspartyl-tRNA-synthetase deficiency). Current Pediatrics. 2015;14(6):724–731. EDN: VGRFEB doi: 10.15690/vsp.v14i6.1483

[34] Колесникова Е.П., Кузенкова Л.М., Савостьянов К.В., и др. Клинические случаи лейкоэнцефалопатии с преимущественным поражением ствола мозга, спинного мозга и повышенным лактатом при МР-спектроскопии (митохондриальная аспартил-тРНК-синтетазная недостаточность) // Вопросы современной педиатрии. 2015. Т. 14, № 6. С. 724–731. EDN: VGRFEB doi: 10.15690/vsp.v14i6.1483

[35] Shchegolev AI, Kulikova GV, Tumanova UN, et al. Increased numbers of syncytial knots and high VEGF expression levels in placental villi among parturient women with COVID-19 depend on the disease severity. Bulletin of Experimental Biology and Medicine. 2021;172(7):102–107. doi: 10.47056/0365-9615-2021-172-7-102-107

[36] Щеголев А.И., Куликова Г.В., Туманова У.Н., и др. Морфометрическая характеристика ворсин плаценты рожениц с COVID-19 // Бюллетень экспериментальной биологии и медицины. 2021. Т. 172, № 7. С. 102–107. doi: 10.47056/0365-9615-2021-172-7-102-107

[37] Fortier AL, Lopes FL, Darricarrere N, et al. Superovulation alters the expression of imprinted genes in the midgestation mouse placenta. Hum Mol Genet. 1998;7(12):2447–2455. doi: 10.1093/hmg/7.12.2447

[38] Fortier A.L., Lopes F.L., Darricarrere N., et al. Superovulation alters the expression of imprinted genes in the midgestation mouse placenta // Hum Mol Genet. 1998. Vol. 7, N. 12. P. 2447–2455. doi: 10.1093/hmg/7.12.2447

[39] Bruno V, Lindau R, Jenmalm MC, et al. First-trimester trophoblasts obtained by chorionic villus sampling maintain tolerogenic and proteomic features in successful pregnancies despite a history of unexplained recurrent pregnancy loss. Am J Reprod Immunol. 2020;84. doi: 10.1111/aji.13314

[40] Bruno V., Lindau R., Jenmalm M.C., et al. First-trimester trophoblasts obtained by chorionic villus sampling maintain tolerogenic and proteomic features in successful pregnancies despite a history of unexplained recurrent pregnancy loss // Am J Reprod Immunol. 2020. Vol. 84. doi: 10.1111/aji.13314.

[41] Kaufmann P, Huppertz B, Frank HG. The fibrinoids of the human placenta: origin, composition and functional relevance. Ann Anat. 1996;178(6):485–501. doi: 10.1016/S0940-9602(96)80102-6

[42] Kaufmann P., Huppertz B., Frank H.G. The fibrinoids of the human placenta: origin, composition and functional relevance // Ann Anat. 1996. Vol. 178, N. 6. P. 485–501. doi: 10.1016/S0940-9602(96)80102-6

[43] Burton GJ, Fowden AL, Thornburg KL. Placental origins of chronic disease. Physiol Rev. 2016;96(4):1509–1565. doi: 10.1152/physrev.00029.2015

[44] Burton G.J., Fowden A.L., Thornburg K.L. Placental origins of chronic disease // Physiol Rev. 2016. Vol. 96, N. 4. P. 1509–1565. doi: 10.1152/physrev.00029.2015

[45] Reyes L, Wolfe B, Golos T. Hofbauer cells: placental macrophages of fetal origin. Results Probl Cell Differ. 2017;62:45–60. doi: 10.1007/978-3-319-54090-0_3

[46] Reyes L., Wolfe B., Golos T. Hofbauer cells: placental macrophages of fetal origin // Results Probl Cell Differ. 2017. Vol. 62. P. 45–60. doi: 10.1007/978-3-319-54090-0_3

[47] Algarroba GN, Rekawek P, Vahanian SA, et al. Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy. Am J Obstet Gynecol. 2020; 223(2):275–278. doi: 10.1016/j.ajog.2020.05.023

[48] Algarroba G.N., Rekawek P., Vahanian S.A., et al. Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy // Am J Obstet Gynecol. 2020. Vol. 223, N. 2. P. 275–278. doi: 10.1016/j.ajog.2020.05.023

[49] Zanin V, Driul L, Zoletto S, et al. Intrauterine fetal death in a COVID positive pregnant woman: a case report and literature review. Minerva Obstet Gynecol. 2022. doi: 10.23736/S2724-606X.22.05149-1

[50] Zanin V., Driul L., Zoletto S., et al. Intrauterine fetal death in a COVID positive pregnant woman: a case report and literature review // Minerva Obstet Gynecol. 2022. doi: 10.23736/S2724-606X.22.05149-1

[51] Konstantinidou AE, Angelidou S, Havaki S, et al. Stillbirth due to SARS-CoV-2 placentitis without evidence of intrauterine transmission to fetus: association with maternal risk factors. Ultrasound Obstet Gynecol. 2022;59(6):813–822. doi: 10.1002/uog.24906

[52] Konstantinidou A.E., Angelidou S., Havaki S., et al. Stillbirth due to SARS-CoV-2 placentitis without evidence of intrauterine transmission to fetus: association with maternal risk factors // Ultrasound Obstet Gynecol. 2022. Vol. 59, N. 6. P. 813–822. doi: 10.1002/uog.24906

[53] Watkins JC, Torous VF, Roberts DJ. Defining severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) placentitis. Arch Pathol Lab Med. 2021;145(11):1341–1349. doi: 10.5858/arpa.2021-0246-SA

[54] Watkins J.C., Torous V.F., Roberts D.J. Defining severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) placentitis // Arch Pathol Lab Med. 2021. Vol. 145, N. 11. P. 1341–1349. doi: 10.5858/arpa.2021-0246-SA

[55] Mendelson CR, Gao L, Montalbano AP. Multifactorial regulation of myometrial contractility during pregnancy and parturition. Front Endocrinol (Lausanne). 2019;10:714. doi: 10.3389/fendo.2019.00714

[56] Mendelson C.R., Gao L., Montalbano A.P. Multifactorial regulation of myometrial contractility during pregnancy and parturition // Front Endocrinol. 2019. Vol. 10. P. 714. doi: 10.3389/fendo.2019.00714

[57] Russian Society of Obstetricians and Gynecologists, LLC “Association of Anesthesiologists-Resuscitators (AAR)”, Association of Obstetric Anesthesiologists-Resuscitators. Preeclampsia. Eclampsia. Edema, proteinuria and hypertensive disorders during pregnancy, childbirth and the postpartum period. Clinical recommendations (treatment protocol). 2021. (In Russ.) Available from: https://cr.minzdrav.gov.ru/recomend/637_1

[58] Российское общество акушеров-гинекологов, ООО «Ассоциация анестезиологов-реаниматологов (ААР)», Ассоциация акушерских анестезиологов-реаниматологов. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Клинические рекомендации (протокол лечения). 2021. Режим доступа: https://cr.minzdrav.gov.ru/recomend/637_1. Дата обращения: 12.12.2023.

RIGHTS & PERMISSIONS

Eсо-Vector